GGrantIndex
Sort

40,608 grants matching prostate cancer

PI-3 Kinase Therapy in Mouse Tumor Models

$544,440
Columbia University Health Sciences · R01 · FY2005 · CA

Mechanisms of Murine Tumor Eradication by Immunotherapy

$544,421
Philip D Greenberg · University Of Washington · R01 · FY2009 · CA

ProstaFluor FDA Trial for Real-Time Margin Detection During Prostatectomy

$544,410
David A. Benaron · Spectros Corporation · R01 · FY2013 · CA

Influences of the Microenvironment on Cancer Stem Cells

$544,406
Hong Wu · University Of California Los Angeles · U01 · FY2013 · CA

TO DEGRADE OF NOT DEGRADE: TARGETING THE ANDROGEN RECEPTOR IN AR-DEPENDENT PROSTATE CANCER

$544,324
Baylor College Of Medicine · · FY2008 · Department of the Army

Development of an Optimal MRI Platform for Prostate Investigations at 7 Tesla

$544,283
Gregory John Metzger · University Of Minnesota · R01 · FY2012 · CA

Efficacy of a Couple-focused, Tailored, Symptom Self-Management mHealth Intervention for Prostate Cancer Patients and Partners

$544,248
Lixin Song · Univ Of North Carolina Chapel Hill · R01 · FY2017 · NR

Clinical Nursing and Data Management Core

$544,151
William Marston Linehan · Division Of Basic Sciences - Nci · ZID · FY2022 · CA

Laboratory of Genitourinary Cancer Pathogenesis Microscopy Core Facility

$544,131
Yvona Ward · Division Of Basic Sciences - Nci · ZIC · FY2014 · CA

Analysis of Tumor Dynamics in Progression and Metastasis

$544,105
Lewis A Chodosh · University Of Pennsylvania · U01 · FY2006 · CA

Hyperpolarized 13C MRSI Monitoring of Pyruvate Metabolism to Assess Drug Action

$544,039
Russell O Pieper · University Of California, San Francisco · P01 · FY2014 · CA

Novel radioimmunoconjugates for targeted alpha-particle therapy of metastatic prostatic cancer

$543,996
Jiang He · University Of Virginia · R01 · FY2019 · CA

Role of Shh in developmental patterning and growth of digit skeleton

$543,989
Susan Mackem · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Image Biomarker Development for TreatmentEfficacy of Prostate Cancer to the Bone

$543,962
Brian D. Ross · University Of Michigan At Ann Arbor · R01 · FY2010 · CA

Selenium Based Chemoprevention - HGPIN

$543,952
Cancer Therapy And Research Center · U01 · FY2005 · CA

Mechanisms of resistance to Androgen Receptor inhibition in prostate cancer

$543,730
David Vanderweele · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Detection of prostate Cancer Specific Signals with Hybrid Multi-Dimensional MRI

$543,654
Aytekin Oto · University Of Chicago · R01 · FY2019 · CA

Serum Antibody Profiling with a Carbohydrate Microarray

$543,615
Jeff Gildersleeve · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

Stroger Hospital of Cook County, Department of Surgery,*

$543,572
Thomas Lad · Hektoen Institute For Medical Research · U10 · FY2010 · CA

Control of Protein Translation in Cancer Pathogenesis

$543,556
Sloan-Kettering Institute For Cancer Res · U01 · FY2004 · CA

Plk1 as a prognostic biomarker for prostate cancer

$543,492
Xiaoqi Liu · University Of Kentucky · R01 · FY2025 · CA

3-dimensional prompt gamma imaging for online proton beam dose verification

$543,456
Lei Ren · University Of Maryland Baltimore · R01 · FY2024 · CA

Novel therapeutics dual targeting intracrine androgen synthesis and AR for advanced prostate cancer

$543,427
Allen C Gao · University Of California At Davis · R01 · FY2022 · CA

Glycoprotein Biomarkers for Early Detection of Aggressive Prostate Cancer

$543,365
Hui Zhang · Johns Hopkins University · U01 · FY2018 · CA

Smoking Cessation for Cervical Cancer Survivors in a Safety Net Healthcare System

$543,287
Jennifer Irvin Vidrine · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2016 · CA